From its inception, Kura Oncology has been dedicated to realizing the promise of precision medicine to help patients with cancer lead better, longer lives. The people at Kura have made monumental progress in bringing that vision to life for people with acute leukemias through our KOMET clinical trial program. This is only the beginning, as we continue to grow into a fully integrated research, development, and commercial organization. #ziftomenib Learn more: https://lnkd.in/eV5q_ts2
Kura Oncology, Inc.’s Post
More Relevant Posts
-
Patients and society won’t reap the benefits of precision oncology unless we democratize this data, that is, make it available to the patients who need it when they need it. With a few practical improvements to current care pathways, we could achieve this, meet the need for urgency, and empower patients. Stacy Hurt 🌻, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/gBkJMKt2 #PrecisionOncology #NovelInsights #PatientsFirst #PatientData #ASCO24
To view or add a comment, sign in
-
Coming out of #ASCO24, we’re excited to further our work in supporting patients living with difficult-to-treat cancers such as gastroesophageal adenocarcinoma (GEA). HER2 has emerged as a compelling target for patients whose cancer displays HER2-positivity, including some GEA patients, which is why testing for HER2-expression in patients diagnosed with GEA is critical to determining the appropriate treatment option. Hear from Elaina Gartner, Vice President Medical, Late-Stage Development, Oncology Clinical Development, as she details more about the role of #HER2 in GEA. https://bit.ly/3Rier2V
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
To view or add a comment, sign in
-
🌐 Discover the Top 10 Oncology CME Conferences in the USA - https://bit.ly/3B4eUk7 🎗️ Cancer is the second leading cause of death in the United States, highlighting the critical need for ongoing education and advancements in oncology. As treatment landscapes evolve, healthcare professionals must stay informed about the latest research and clinical practices. 📊 Attending oncology CME conferences is a valuable opportunity to gain cutting-edge knowledge, network with experts, and enhance your clinical skills. 🩺 This blog highlights the Top 10 Oncology CME Conferences in the USA that provide exceptional learning experiences and insights into pressing oncology issues. #OncologyCME #MedicalEducation #CancerCare #HealthcareProfessionals #eMedEvents #OncologyConferences
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
To view or add a comment, sign in
-
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology
Accelerate precision oncology by empowering and educating patients, sites, and physicians
share.parexel.social
To view or add a comment, sign in
-
What knowledge, skills, and attitudes are required by oncology pharmacists in Canada? On Tuesday, October 1, CAPhO will unveil the Competencies for Oncology Pharmacists in Canada document. Stay tuned to learn how these competencies will shape the future of cancer care and enhance our profession! #CAPhO #ACPhO #CAPhOCompetencies #OncologyCompetencies
To view or add a comment, sign in
21,530 followers